SolveBio

Precision Medicine Data Management Softwaresolvebio.com

SolveBio was a New York-based precision medicine data infrastructure company that built an enterprise SaaS platform to integrate clinical sample and biomarker data for biopharma and translational research teams, targeting precision oncology workflows. It was acquired by QuartzBio in January 2023.

Company typePrivate
Founded2013
HeadquartersNew York, United States
Headcount11–50
GTM typeB2B
OfferingSoftware

What SolveBio does

SolveBio was a New York-based precision medicine data infrastructure company founded in 2013 that operated an enterprise-grade data management platform purpose-built for clinical sample and biomarker data. The platform integrated genomic and clinical data sources to address fragmented data management across precision medicine workflows — including sample lifecycle tracking, biomarker data QC, and data silos in clinical trials — with a stated focus on precision oncology and personalized therapeutic development. SolveBio's core technology was a domain-specialized data layer with proprietary schema and integration capabilities that allowed sponsors and translational research teams to unify sample provenance, chain-of-custody records, and biomarker outputs across disparate systems. The company operated a SaaS business model with non-publicly disclosed pricing, sold to biopharma, clinical research, and precision medicine teams, and was bootstrapped with a small headcount (11–50 employees).

In January 2023, SolveBio was acquired by QuartzBio, a subsidiary of Precision for Medicine, and ceased to operate as an independent entity. The acquisition was driven by QuartzBio's strategy to consolidate the precision medicine software sector and enhance its genomic and biomarker management capabilities by absorbing SolveBio's enterprise data platform. Following the deal, SolveBio's technology was integrated into QuartzBio's broader Sample and Biomarker Intelligence SaaS offering, which has since expanded to include Sample Intelligence, Biomarker Intelligence, and Agent Intelligence modules serving clinical-stage biopharma customers. SolveBio's standalone revenue, customer count, and pricing terms were never publicly disclosed, and the company's growth trajectory as an independent entity was modest — total disclosed capital was approximately $3.5M across a 2014 venture round, a 2015 insider round, and a 2018 NIH grant.

SolveBio firmographics

Firmographics

Name: SolveBio
Legal name: SolveBio Inc.
Website: https://solvebio.com
Company type: Private
Founded year: 2013
Operating status: Acquired
Headcount range: 11–50 employees
Short description: SolveBio was a New York-based precision medicine data infrastructure company that built an enterprise SaaS platform to integrate clinical sample and biomarker data for biopharma and translational research teams, targeting precision oncology workflows. It was acquired by QuartzBio in January 2023.
Ownership category
akta.pro rank

SolveBio industry classification

Industry

Product category: Precision Medicine Data Management Software
NAICS: Computer Systems Design and Related Services (54151)
SIC: Services-Prepackaged Software (7372)
akta.pro primary industry: Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
akta.pro secondary industry: Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

Genomic data management
Biomarker intelligence
Clinical sample tracking
Precision medicine platform
Enterprise bioinformatics

Where SolveBio is headquartered

Location

Headquarters

HQ city: New York
HQ country: United States
HQ region: North America

Markets served

SolveBio business model

Business model

GTM type: B2B
Offering type: Software
Cost components: Personnel, Technology or R&D, Operations, Marketing or Sales

SolveBio product offering

Product offering

Core offering

SolveBio provided an enterprise-grade data management platform for clinical sample and biomarker data within precision medicine workflows. The platform integrated genomic and clinical data to streamline management of biospecimens and biomarkers across clinical trial lifecycles, supporting precision oncology and personalized therapeutics research.

Differentiator

Problem solved

Functional benefit

Products and services

Enterprise Data Management Platform An enterprise-grade SaaS platform specifically designed for clinical sample and biomarker data management within precision medicine workflows, integrating genomic and clinical data to support precision oncology and personalized therapeutics.

Companies that use SolveBio

Customer profile

Ideal customer profiles1 record

SolveBio technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

SolveBio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

QuartzBio (Precision for Medicine)coreStrategic or Co-development Partner · 1 January 2023In January 2023, QuartzBio, part of Precision for Medicine based in the US, acquired SolveBio Inc. to strengthen its SaaS offerings by integrating SolveBio's enterprise data management platform for clinical sample and biomarker data. This acquisition was part of QuartzBio's strategy to enhance its genomic and biomarker management capabilities and consolidate the precision medicine software sector.

Recent moves5 records

Expansion highlights3 records

SolveBio competitors and assessment

Company assessment

Direct peers

Genospace (acquired by Tempus): Genospace built an integrated precision medicine data platform for clinical and genomic data — the closest direct analog to SolveBio's clinical sample and biomarker data platform, also exiting via strategic acquisition (Tempus, 2023).
Dotmatics: Dotmatics provides scientific informatics (LIMS, ELN, and translational data management) for life sciences R&D, directly comparable to SolveBio's biomarker and clinical sample data focus.
LabWare: LabWare is a leading LIMS/ELN vendor serving clinical, biorepository, and translational laboratory data workflows — overlapping with SolveBio's clinical sample lifecycle management.
Benchling: Benchling's cloud platform centralizes biological and experimental data for life sciences R&D, including biomarker and sample tracking, making it a direct functional peer for SolveBio's enterprise data management approach.
Aridhia: Aridhia's DRE platform supports clinical and translational research data integration and analytics, serving a similar biomedical informatics niche as SolveBio.
BioFortis (acquired by LabCorp): BioFortis offered clinical and translational research informatics with a focus on integrating clinical, lab, and biospecimen data — a near-direct functional peer to SolveBio, also acquired by a larger diagnostics/services company.

Broad incumbents

Veeva Systems: Veeva's Clinical and Vault platforms provide clinical trial and life sciences data management at enterprise scale, including biomarker and sample workflow capabilities that overlap directly with SolveBio's offering.
Medidata Solutions (Dassault Systèmes): Medidata's Rave clinical trial platform and biospecimen/biomarker management modules address the same clinical trial data integration and translational workflow needs that SolveBio targeted.
Oracle Health Sciences (Clinical One): Oracle's Clinical One and Translational Research Center address clinical trial and biomarker data integration at enterprise scale, competing with SolveBio for precision medicine R&D data workflows.

Emerging players

OpenClinica: OpenClinica provides electronic data capture and clinical trial data management, with overlap to SolveBio's clinical data integration in translational and biomarker-focused studies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

SolveBio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SolveBio leadership team

Management profile

Number of profiles

Profiles2 records

SolveBio funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SolveBio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SolveBio

What does SolveBio do?

Is SolveBio a public or private company?

SolveBio is a private company. It is classified as corporate owned and is currently acquired.

When was SolveBio founded?

SolveBio was founded in 2013. It employs 11 to 50 people.

Where is SolveBio based?

SolveBio is headquartered in New York, United States, in the North America region.

Who are SolveBio's main competitors?

Direct peers on record are Genospace (acquired by Tempus), Dotmatics, LabWare, Benchling, Aridhia and BioFortis (acquired by LabCorp). Broad incumbents are Veeva Systems, Medidata Solutions (Dassault Systèmes) and Oracle Health Sciences (Clinical One). OpenClinica is listed as an emerging player.

Does SolveBio have an API?

No public API is recorded for SolveBio.

What industry is SolveBio in?

SolveBio's product category is Precision Medicine Data Management Software. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 54151 and its SIC code is 7372.